ORLANDO, Fla. — The glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced cardiovascular events and reduced the risk of progression to diabetes by 73% in people with ...
(Bloomberg) -- Selecta Group BV and a group of its bondholders asked a federal judge to dismiss a lawsuit accusing them of violating US antitrust laws as creditors made a pact among themselves to ...
Good morning, and welcome to the Selecta Bio Fourth Quarter 2022 Earnings Release Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results